Sandoz Adds To Anti-Infectives With Astellas Mycamine Deal

Global Micafungin Rights Valued At Up To $75m Upfront Plus Milestone Payments

Sandoz logo on building
Sandoz and Astellas have struck a deal for Mycamine • Source: Shutterstock

More from Deals

More from Business